|
All Business Categories
|
Vandalia Research , Inc.
West Virginia, USA About Vandalia Research - Vandalia Research, Inc. is a life sciences research company based in West Virginia, and was formed as a direct result of the above E-team research. Vandal... Vital Probes Inc Pennsylvania, USA VPI is committed to becoming a world leader in the select pathogen detection and vaccination markets as well as providing a superior first responder solution for biodefense. Please... Evotope Biosciences Inc New York, USA To further develop Evotope's platform technology to identify and modulate cryptic allosteric regulatory sites on validated drug discovery target surfaces. Evotope Biosciences, Inc.... Etubics Corporation Washington, USA Etubics Corporation is a biopharmaceutical company that is developing "next generation" vector vaccines for protection and therapeutic uses. The Company's products will expand the ... 21st Century Biochemicals , LLC Massachusetts, USA 21st Century Biochemicals was founded by Dr. Jordan B. Fishman along with a team of talented scientists. Dr. Fishman received a dual Ph.D. in Biochemistry and Carcinogenesis/Toxico... British Columbia, Canada Network Immunology Inc. is a vaccine company. The company's focus is to commercialize a preventive HIV vaccine invented in 2005 by Dr. Geoffrey W. Hoffmann, the Chief Scientist of ... Centocor , Inc. Pennsylvania, USA Centocor, Inc. is a leading biopharmaceutical company that creates, acquires, and markets cost-effective therapies that yield long-term benefits for patients and the healthcare com... OSI Pharmaceuticals , Inc. New York, USA OSI Pharmaceuticals is committed to "shaping medicine and changing lives" by discovering, developing and commercializing high-quality and novel pharmaceutical products that extend ... ICOS Corporation Washington, USA ICOS Corporation, a biotechnology company headquartered in Bothell, Washington, is dedicated to bringing innovative therapeutics to patients. Through Lilly ICOS LLC, ICOS is market... Rinat Neuroscience Corporation California, USA Rinat is also developing RN1219 for the potential treatment of Alzheimer's disease. RN1219, a humanized monoclonal antibody, has been shown to reduce amyloid plaque in pre-clinical...
First
Prev
[5]
[10]
[14]
[19]
[20]
[21]
[22]
[23]
[24]
[25]
[26]
[27]
[28]
29
[30]
[31]
[32]
[33]
[34]
[35]
[36]
[37]
[38]
[754]
[1470]
[2186]
Next
Last
|
